Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,422,846
-
Share change
-
+2,952,734
-
Total reported value
-
$43,083,190
-
Put/Call ratio
-
129%
-
Price per share
-
$3.21
-
Number of holders
-
73
-
Value change
-
+$8,036,964
-
Number of buys
-
45
-
Number of sells
-
29
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q2 2022
As of 30 Jun 2022,
Humacyte, Inc. - COM (HUMA) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,422,846 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., York Capital Management Global Advisors, LLC, UBS OCONNOR LLC, GEODE CAPITAL MANAGEMENT, LLC, Prescott General Partners LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and LPL Financial LLC.
This page lists
73
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.